10 completed. 6 Phase 3, 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 4 | 3 | Completed 3 |
Follow Promomed, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis Double-Stranded RNA sodium salt, Placebo - COVID-19 | Phase 3 | Completed | Promomed, LLC | 800 | 2022-06-09 | 2023-02-16 |
| Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19 Structural and functional MRI, Ethyl methyl hydroxypyridine succinate + Meldonium, Placebo - Asthenia, COVID-19 | Phase 4 | Completed | Promomed, LLC | 30 | 2022-05-18 | 2023-07-13 |
| Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19 Ethyl methyl hydroxypyridine succinate + Meldonium, Placebo - Asthenia, COVID-19 | Phase 4 | Completed | Promomed, LLC | 160 | 2022-04-05 | 2023-07-13 |
| Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19 Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly, Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate inhaled, Standard of care - COVID-19 | Phase 3 | Completed | Promomed, LLC | 313 | 2022-02-28 | 2023-04-06 |
| Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19 Molnupiravir (Esperavir), Standard of care - COVID-19 | Phase 3 | Completed | Promomed, LLC | 240 | 2021-12-01 | 2022-10-27 |
| Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19 Favipiravir, Remdesivir - COVID-19 | Phase 3 | Completed | Promomed, LLC | 217 | 2021-08-11 | 2022-01-11 |
| Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population nirmatrelvir/ritonavir, Standard of care - COVID-19 | Phase 3 | Completed | Promomed, LLC | 264 | 2021-02-17 | 2023-04-10 |
| Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity metformin+sibutramine, sibutramine+ microcrystalline cellulose - Obesity | Phase 4 | Completed | Promomed, LLC | 240 | 2020-07-03 | 2023-04-24 |
| Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 Favipiravir, Standard of care - COVID-19 | Phase 3 | Completed | Promomed, LLC | 200 | 2020-05-21 | 2020-11-05 |
| The PRIMAVERA Study: Reduxine Safety Monitoring in Patients With Alimentary Obesity Alimentary Obesity | Completed | Promomed, LLC | 98774 | 2012-11-01 | 2024-01-19 |
COVID-19 (8) · Asthenia (2) · Cognitive Dysfunction (1) · Coronavirus Infections (1) · Fatigue Syndrome, Chronic (1) · Mental Fatigue (1) · Obesity (1) · Pneumonia (1)
Standard of Care (4) · 3-(2,2,2-trimethylhydrazine)propionate (2) · favipiravir (2) · molnupiravir (1) · nirmatrelvir and ritonavir drug combination (1) · remdesivir (1)
Russia (9)
Dmitriy Pushkar (2) · Dmitriy Pushkar, Academician (2) · Dmitriy Pushkar, MD, Academic (1) · Ivan I Dedov, academician (1) · Marine Tanashyan, MD, PhD (1) · Tatyana Demidova (1)